(S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine

Catalog No.: 
ACNOZT682
CAS No.: 
778565-93-8
Molecular Formula: 
C8H7BrF3N
Molecular Weight: 
254.05
(S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$146.00In stockInquiry
5g97%$715.00In stockInquiry
25g97%$3289.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine
IUPAC Name(S)-1-(4-bromophenyl)-2,2,2-trifluoroethan-1-amine
MDL No.MFCD07374593
Molecular FormulaC8H7BrF3N
Molecular Weight254.05
SMILESN[C@@H](C1=CC=C(Br)C=C1)C(F)(F)F
InChI KeyZUFCCCNTJRQNCF-ZETCQYMHSA-N
Synonym(1S)-1-(4-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE;(S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine;(1S)-1-(4-Bromophenyl)-2,2,2-trifluoroethan-1-amine;(S)-1-(4-BROMO-PHENYL)-2,2,2-TRIFLUORO-ETHYLAMINE;(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethanamine;(S)-1-(4-bromophenyl)-2,2,2-trifluoroethan-1-amine;Benzenemethanamine, 4-bromo-α-(trifluoromethyl)-, (αS)-;(S)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine - [B91400]
CAS No.778565-93-8
PubChem CID12164755

Synthetic Route by SureRoute

1. ACNOZT682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZXEL320 route compound structure diagram
    ACZXEL32016184-89-7In Stock
  2. Then
  3. ACNOZT682 route product structure diagram
    ACNOZT682778565-93-8In Stock
Inquiry

2. ACNOZT682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNOZT682 route product structure diagram
    ACNOZT682778565-93-8In Stock
Inquiry

3. ACNOZT682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNOZT682 route product structure diagram
    ACNOZT682778565-93-8In Stock
Inquiry

Comments (0)